Inhibition of IκB Kinase-Nuclear Factor-κB Signaling Pathway by 3,5-Bis(2-flurobenzylidene)piperidin-4-one (EF24), a Novel Monoketone Analog of Curcumin
Andrea L. Kasinski(Purdue University West Lafayette), Haian Fu(Emory University), Dennis C. Liotta(Emory University), Fadlo R. Khuri(American University of Beirut Medical Center), Mamoru Shoji(Emory University), Cun‐Yu Wang(University of California, Los Angeles), Aiming Sun(Emory University), James P. Snyder(Emory University), Shala L. Thomas(Emory University), Jing Zhao(Stanford University), Yuhong Du(Emory University), Shi‐Yong Sun(Emory University)
Cited by 158
Related Papers
Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial
|The Lancet Oncology|2013|748
Correction: Corrigendum: The OncoPPi network of cancer-focused protein–protein interactions to inform biological insights and therapeutic strategies
|Nature Communications|2017|645
Adenovirus-Mediated p53 Gene Transfer in Advanced Non-Small-Cell Lung Cancer
|JNCI Journal of the National Cancer Institute|1999|497
Cancer Prevention With Natural Compounds
|Seminars in Oncology|2010|481
Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294
|Nature Structural & Molecular Biology|2009|306